Unum is a Cambridge, MA-based company developing novel cellular therapies to treat a wide range of cancers. Our investigational therapies work as combination products, pairing a tumor-specific antibody together with genetically modified T cells isolated from the patient. Unlike other approaches, our investigational therapies are not restricted to a particular target and may be used in many different cancer types. We are currently clinically testing our product candidates in patients with lymphoma and multiple myeloma and are expanding our efforts to encompass several additional cancer types in the near future.
Copyright West LLC. Minimum 15 minutes delayed.
May 13, 2019